Amgen and Boston Children's Hospital enter collaboration to target new pain genes
Amgen and Boston Children's Hospital announced a neuroscience research collaboration aimed at identifying novel pain targets based on human genetic analyses. The one-year collaboration will focus on patients with genetic anomalies of pain sensitivity. October 16, 2017